The Latin America, Middle East and Africa Mental Health Screening Market would witness market growth of 15.3% CAGR during the forecast period (2024-2031).
The Brazil market dominated the LAMEA Mental Health Screening Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $45.7 million by 2031. The Argentina market is registering a CAGR of 16% during (2024 - 2031). Additionally, The UAE market would showcase a CAGR of 14.9% during (2024 - 2031).
Numerous significant factors have contributed to the substantial expansion of the mental health screening market in recent years. One of the primary drivers of this growth is the rising prevalence of mental health disorders.
Additionally, as a leading cause of disability on a global scale, mental health disorders impact one in every four individuals, as reported by the World Health Organization (WHO). Moreover, in many Western countries, mental disorders are the leading cause of disability, responsible for 30-40% of chronic sick leave and costing some 3% of GDP.
The demand for mental health screening tools in the LAMEA region is steadily growing, fueled by concerning statistics that underscore the significant burden of mental health disorders in the region. In the Middle East and North Africa (MENA) region, which is home to almost 140 million young people aged 10-24 years, mental disorders and intentional self-harm account for almost a quarter of the total disease burden.
Based on Age Group, the market is segmented into Adults (age 19-64 years), Children & Adolescents (age 0-18 years), and Seniors (age 65 and above). Based on Setting, the market is segmented into Clinical Settings, Educational Institutions & Others, and Workplace/Corporate Programs & Online Platforms. Based on Technology, the market is segmented into Telehealth & Virtual Care Solutions, Self-screening mHealth Apps, AI-based Screening Tools, and Continuous Monitoring Wearable Devices & Others. Based on Screening Method, the market is segmented into Self-reported Questionnaires & Surveys, Clinical Interviews, Observation-based Assessments, and Biomarker Testing. Based on Application, the market is segmented into Physiological Disorders (Depression & Anxiety, Eating Disorder, Post-Traumatic Stress Disorder (PTSD), Bipolar Disorder, and Others), Psychiatric Disorders (Attention Deficit Hyperactivity Disorder (ADHD), Psychotic Disorder, Dissociative Disorder, Obsessive Compulsive Disorder, Schizophrenia, and Others), Cognitive Disorders (Cognitive Impairment, Dementia, and Alzheimer's Disease & Others), and Behavioral Disorders (Self-Harm, Aggression, Sleep Disorder, Social Withdrawal, Dissociative Disorder, Hyperactivity, and Others). Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The Brazil market dominated the LAMEA Mental Health Screening Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $45.7 million by 2031. The Argentina market is registering a CAGR of 16% during (2024 - 2031). Additionally, The UAE market would showcase a CAGR of 14.9% during (2024 - 2031).
Numerous significant factors have contributed to the substantial expansion of the mental health screening market in recent years. One of the primary drivers of this growth is the rising prevalence of mental health disorders.
Additionally, as a leading cause of disability on a global scale, mental health disorders impact one in every four individuals, as reported by the World Health Organization (WHO). Moreover, in many Western countries, mental disorders are the leading cause of disability, responsible for 30-40% of chronic sick leave and costing some 3% of GDP.
The demand for mental health screening tools in the LAMEA region is steadily growing, fueled by concerning statistics that underscore the significant burden of mental health disorders in the region. In the Middle East and North Africa (MENA) region, which is home to almost 140 million young people aged 10-24 years, mental disorders and intentional self-harm account for almost a quarter of the total disease burden.
Based on Age Group, the market is segmented into Adults (age 19-64 years), Children & Adolescents (age 0-18 years), and Seniors (age 65 and above). Based on Setting, the market is segmented into Clinical Settings, Educational Institutions & Others, and Workplace/Corporate Programs & Online Platforms. Based on Technology, the market is segmented into Telehealth & Virtual Care Solutions, Self-screening mHealth Apps, AI-based Screening Tools, and Continuous Monitoring Wearable Devices & Others. Based on Screening Method, the market is segmented into Self-reported Questionnaires & Surveys, Clinical Interviews, Observation-based Assessments, and Biomarker Testing. Based on Application, the market is segmented into Physiological Disorders (Depression & Anxiety, Eating Disorder, Post-Traumatic Stress Disorder (PTSD), Bipolar Disorder, and Others), Psychiatric Disorders (Attention Deficit Hyperactivity Disorder (ADHD), Psychotic Disorder, Dissociative Disorder, Obsessive Compulsive Disorder, Schizophrenia, and Others), Cognitive Disorders (Cognitive Impairment, Dementia, and Alzheimer's Disease & Others), and Behavioral Disorders (Self-Harm, Aggression, Sleep Disorder, Social Withdrawal, Dissociative Disorder, Hyperactivity, and Others). Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- Proem Heath, Inc.
- SonderMind, Inc
- ResMed, Inc.
- Headspace, Inc.
- Quartet Inc.
- Fitbit, Inc. (Google LLC)
- Sonde Health, Inc. (Puretech Health Plc)
- Koninklijke Philips N.V
- Apple, Inc
- Canary Speech, Inc
Market Report Segmentation
By Age Group- Adults (age 19-64 years)
- Children & Adolescents (age 0-18 years)
- Seniors (age 65 and above)
- Clinical Settings
- Educational Institutions & Others
- Workplace/Corporate Programs & Online Platforms
- Telehealth & Virtual Care Solutions
- Self-screening mHealth Apps
- AI-based Screening Tools
- Continuous Monitoring Wearable Devices & Others
- Self-reported Questionnaires & Surveys
- Clinical Interviews
- Observation-based Assessments
- Biomarker Testing
- Physiological Disorders
- Depression & Anxiety
- Eating Disorder
- Post-Traumatic Stress Disorder (PTSD)
- Bipolar Disorder
- Others
- Psychiatric Disorders
- Attention Deficit Hyperactivity Disorder (ADHD)
- Psychotic Disorder
- Dissociative Disorder
- Obsessive Compulsive Disorder
- Schizophrenia
- Others
- Cognitive Disorders
- Cognitive Impairment
- Dementia
- Alzheimer's Disease & Others
- Behavioral Disorders
- Self-Harm
- Aggression
- Sleep Disorder
- Social Withdrawal
- Dissociative Disorder
- Hyperactivity
- Others
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. LAMEA Mental Health Screening Market by Age Group
Chapter 6. LAMEA Mental Health Screening Market by Setting
Chapter 7. LAMEA Mental Health Screening Market by Technology
Chapter 8. LAMEA Mental Health Screening Market by Screening Method
Chapter 9. LAMEA Mental Health Screening Market by Application
Chapter 10. LAMEA Mental Health Screening Market by Country
Chapter 11. Company Profiles
Companies Mentioned
- Proem Heath, Inc.
- SonderMind, Inc
- ResMed, Inc.
- Headspace, Inc.
- Quartet Inc.
- Fitbit, Inc. (Google LLC)
- Sonde Health, Inc. (Puretech Health Plc)
- Koninklijke Philips N.V
- Apple, Inc
- Canary Speech, Inc
Methodology
LOADING...
